A case of nail psoriasis improved with treatment by risankizumab

Nail psoriasis causes significant aesthetic and functional disabilities. The treatment of nail psoriasis is essential to improve the health outcomes and quality of life among patients. Pain associated with intralesional injections, inadequate penetration into the nail and underlying tissue, poor adh...

Descripción completa

Detalles Bibliográficos
Autores principales: AlAjlan, Abdulmajeed, Qasim, Raghda, AlTassan, Fatimah, Qadoumi, Tala, AlKaff, Tuqa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693772/
https://www.ncbi.nlm.nih.gov/pubmed/36447464
http://dx.doi.org/10.1093/omcr/omac127
_version_ 1784837628116336640
author AlAjlan, Abdulmajeed
Qasim, Raghda
AlTassan, Fatimah
Qadoumi, Tala
AlKaff, Tuqa
author_facet AlAjlan, Abdulmajeed
Qasim, Raghda
AlTassan, Fatimah
Qadoumi, Tala
AlKaff, Tuqa
author_sort AlAjlan, Abdulmajeed
collection PubMed
description Nail psoriasis causes significant aesthetic and functional disabilities. The treatment of nail psoriasis is essential to improve the health outcomes and quality of life among patients. Pain associated with intralesional injections, inadequate penetration into the nail and underlying tissue, poor adherence to therapy, limited efficacy and recurrent relapses are among the many challenging issues with topical therapy. While conventional systemic therapies are still useful and often appropriate for some patients, current evidence indicates that highly selective agents including anti-tumor necrosis factor-alpha, anti-interleukin (IL)-17 and anti-IL-12/23 antibodies that are primarily available for plaque psoriasis and psoriatic arthritis have also demonstrated long-term efficacy in the treatment of nail psoriasis. We report a case of nail psoriasis improved with treatment by risankizumab.
format Online
Article
Text
id pubmed-9693772
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96937722022-11-28 A case of nail psoriasis improved with treatment by risankizumab AlAjlan, Abdulmajeed Qasim, Raghda AlTassan, Fatimah Qadoumi, Tala AlKaff, Tuqa Oxf Med Case Reports Case Report Nail psoriasis causes significant aesthetic and functional disabilities. The treatment of nail psoriasis is essential to improve the health outcomes and quality of life among patients. Pain associated with intralesional injections, inadequate penetration into the nail and underlying tissue, poor adherence to therapy, limited efficacy and recurrent relapses are among the many challenging issues with topical therapy. While conventional systemic therapies are still useful and often appropriate for some patients, current evidence indicates that highly selective agents including anti-tumor necrosis factor-alpha, anti-interleukin (IL)-17 and anti-IL-12/23 antibodies that are primarily available for plaque psoriasis and psoriatic arthritis have also demonstrated long-term efficacy in the treatment of nail psoriasis. We report a case of nail psoriasis improved with treatment by risankizumab. Oxford University Press 2022-11-24 /pmc/articles/PMC9693772/ /pubmed/36447464 http://dx.doi.org/10.1093/omcr/omac127 Text en © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
AlAjlan, Abdulmajeed
Qasim, Raghda
AlTassan, Fatimah
Qadoumi, Tala
AlKaff, Tuqa
A case of nail psoriasis improved with treatment by risankizumab
title A case of nail psoriasis improved with treatment by risankizumab
title_full A case of nail psoriasis improved with treatment by risankizumab
title_fullStr A case of nail psoriasis improved with treatment by risankizumab
title_full_unstemmed A case of nail psoriasis improved with treatment by risankizumab
title_short A case of nail psoriasis improved with treatment by risankizumab
title_sort case of nail psoriasis improved with treatment by risankizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693772/
https://www.ncbi.nlm.nih.gov/pubmed/36447464
http://dx.doi.org/10.1093/omcr/omac127
work_keys_str_mv AT alajlanabdulmajeed acaseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT qasimraghda acaseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT altassanfatimah acaseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT qadoumitala acaseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT alkafftuqa acaseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT alajlanabdulmajeed caseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT qasimraghda caseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT altassanfatimah caseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT qadoumitala caseofnailpsoriasisimprovedwithtreatmentbyrisankizumab
AT alkafftuqa caseofnailpsoriasisimprovedwithtreatmentbyrisankizumab

Ejemplares similares